If you made any changes in Pure these will be visible here soon.

Research Output

Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Grimm, S. E., Armstrong, N., Ramaekers, B. L. T., Pouwels, X., Lang, S., Petersohn, S., Riemsma, R., Worthy, G., Stirk, L., Ross, J., Kleijnen, J. & Joore, M. A., May 2019, In : Pharmacoeconomics. 37, 5, p. 655-667 13 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Grimm, S. E., Fayter, D., Ramaekers, B. L. T., Petersohn, S., Riemsma, R., Armstrong, N., Pouwels, X., Witlox, W., Noake, C., Worthy, G., Kleijnen, J. & Joore, M. A., Oct 2019, In : Pharmacoeconomics. 37, 10, p. 1195-1207 13 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access